Traws Pharma, Inc. (TRAW)

Traws Pharma Statistics

Total Valuation

Traws Pharma has a market cap or net worth of $20.46 million. The enterprise value is $14.04 million.

Market Cap	20.46M
Enterprise Value	14.04M

Important Dates

The last earnings date was Thursday, November 13, 2025, before market open.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Traws Pharma has 7.99 million shares outstanding. The number of shares has increased by 570.57% in one year.

Current Share Class	7.99M
Shares Outstanding	7.99M
Shares Change (YoY)	+570.57%
Shares Change (QoQ)	+51.50%
Owned by Insiders (%)	5.43%
Owned by Institutions (%)	8.75%
Float	5.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.99
Forward PS	334.26
PB Ratio	4.02
P/TBV Ratio	10.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.93
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.22

Current Ratio	1.22
Quick Ratio	1.07
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -1,059.63% and return on invested capital (ROIC) is -785.48%.

Return on Equity (ROE)	-1,059.63%
Return on Assets (ROA)	-92.29%
Return on Invested Capital (ROIC)	-785.48%
Return on Capital Employed (ROCE)	-346.47%
Revenue Per Employee	$406,571
Profits Per Employee	-$1.31M
Employee Count	7
Asset Turnover	0.27
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.60% in the last 52 weeks. The beta is 1.75, so Traws Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.75
52-Week Price Change	-42.60%
50-Day Moving Average	2.34
200-Day Moving Average	2.08
Relative Strength Index (RSI)	57.66
Average Volume (20 Days)	579,029

Short Selling Information

The latest short interest is 54,098, so 0.68% of the outstanding shares have been sold short.

Short Interest	54,098
Short Previous Month	74,502
Short % of Shares Out	0.68%
Short % of Float	0.94%
Short Ratio (days to cover)	0.21

Income Statement

In the last 12 months, Traws Pharma had revenue of $2.85 million and -$9.16 million in losses. Loss per share was -$1.38.

Revenue	2.85M
Gross Profit	2.85M
Operating Income	-15.79M
Pretax Income	-13.31M
Net Income	-9.16M
EBITDA	-15.77M
EBIT	-15.79M
Loss Per Share	-$1.38

Balance Sheet

The company has $6.42 million in cash and n/a in debt, giving a net cash position of $6.42 million or $0.80 per share.

Cash & Cash Equivalents	6.42M
Total Debt	n/a
Net Cash	6.42M
Net Cash Per Share	$0.80
Equity (Book Value)	4.55M
Book Value Per Share	0.64
Working Capital	1.74M

Cash Flow

Operating Cash Flow	-19.47M
Capital Expenditures	n/a
Free Cash Flow	-19.47M
FCF Per Share	-$2.44

Margins

Gross Margin	100.00%
Operating Margin	-554.64%
Pretax Margin	-467.64%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Traws Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-570.57%
Shareholder Yield	-570.57%
Earnings Yield	-44.76%
FCF Yield	-95.16%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 23, 2024. It was a reverse split with a ratio of 1:25.

Last Split Date	Sep 23, 2024
Split Type	Reverse
Split Ratio	1:25

Scores

Traws Pharma has an Altman Z-Score of -73.92 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-73.92
Piotroski F-Score	2